Neurology

• 

  Publication Venue For

  • Association of Pace of Aging Measured by Blood-Based DNA Methylation With Age-Related Cognitive Impairment and Dementia..  99:e1402-e1413. 2022
  • Clinical Reasoning: A 2-Day-Old Boy With Sudden Cardiac Arrest and Encephalopathy..  97:e1743-e1746. 2021
  • Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology (vol 96, pg 262, 2021).  96:296-296. 2021
  • Clinical Reasoning: An 11-year-old girl with focal seizures, fevers, and unilateral, enhancing cortical lesions..  95:e3153-e3159. 2020
  • Bing-Neel syndrome mimicking a meningioma.  95:838-839. 2020
  • Five years ago..  10.1212/WNL.0000000000011228. 2020
  • Long-term outcomes of adult patients with ependymoma..  90:P6.150-P6.150. 2018
  • Author response: International consensus guidance for management of myasthenia gravis: Executive summary.  88:505-506. 2017
  • Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions.  84:632-633. 2015
  • Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore..  80:1621. 2013
  • Albert Heyman, MD (1916-2012).  80:1184-1185. 2013
  • Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore..  79:1259-1267. 2012
  • Reply from the authors.  76:1680-1681. 2011
  • Calibrated finger rub auditory screening test (CALFRAST).  72:1595-1600. 2009
  • Effects of Adjunctive Armodafinil on Patients with Schizophrenia.  72:A336-A336. 2009
  • Epilepsy-associated bone mineral density loss should be prevented (vol 70, pg 166, 2008).  71:228-228. 2008
  • Reply from the editorialist [2].  69:1469-1470. 2007
  • Reply from the editorialist [2].  69:1061-1062. 2007
  • Reply from the authors [2].  69:222. 2007
  • Two randomized vitamin D trials in ambulatory patients on anticonvulsants: Impact on bone - Reply.  68:1959-1959. 2007
  • Reply from the authors [4].  68:1749. 2007
  • Reply from the authors [5].  68:1871. 2007
  • Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke.  66:1745-1746. 2006
  • The role of radiotracer imaging in Parkinson disease.  64:208-215. 2005
  • Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS)..  62:968-970. 2004
  • Acute management of migraine: Highlights of the US Headache Consortium.  60. 2003
  • Immunization and MS: a summary of published evidence and recommendations..  59:1837-1843. 2002
  • Homocysteine testing in patients with acute ischemic stroke..  59:1541-1546. 2002
  • Narrowing in on the causative defect of an intriguing X-linked myopathy with excessive autophagy..  59:596-601. 2002
  • Brain structural abnormalities in young children with autism spectrum disorder..  59:184-192. 2002
  • Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association)..  59:13-22. 2002
  • Neurology residency training at the millennium..  58:1454-1460. 2002
  • Effect of antiepileptic drugs on bone density in ambulatory patients..  58:1348-1353. 2002
  • Emergency craniotomy for intracerebral hemorrhage: when doesn't it help and does it ever help?.  58:1325-1326. 2002
  • Mifepristone (RU 486) for Alzheimer's disease..  58:1436. 2002
  • Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage in mice.  58:A367-A367. 2002
  • Neuropsychological and psychiatric sequelae of pallidotomy for PD: clinical trial findings..  58:858-865. 2002
  • B cells and epilepsy: the odd couple..  58:677-678. 2002
  • Functional changes in temporal lobe activity during transient global amnesia..  58:638-641. 2002
  • Neurophysiological correlates of age-related changes in human motor function..  58:630-635. 2002
  • Paraneoplastic stiff-person syndrome: no tumor progression over 5 years..  58:148. 2002
  • Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study..  57:2210-2216. 2001
  • Low rate of complications of cerebral angiography in routine clinical practice..  57:2012-2014. 2001
  • Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke..  57:2120-2122. 2001
  • Plasmapheresis in rasmussen's encephalitis.  57. 2001
  • Plasmapheresis in Rasmussen's encephalitis. 1996..  57:S37-S41. 2001
  • Daytime sleepiness and other sleep disorders in Parkinson's disease..  57:1392-1396. 2001
  • Improving patient selection for coagulopathy testing in the setting of acute ischemic stroke..  57:1333-1335. 2001
  • Progression of impairment in patients with vascular cognitive impairment without dementia..  57:714-716. 2001
  • Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals..  57:305-314. 2001
  • Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage..  57:18-24. 2001
  • Cortical localization of reading in normal children: an fMRI language study..  57:47-54. 2001
  • Use and cost of outpatient visits of AD patients: CERAD XXII..  56:1706-1711. 2001
  • Hormone replacement therapy and ischemic stroke severity in women: a case-control study..  56:1304-1307. 2001
  • Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology..  56:1154-1166. 2001
  • Attention to location or sensation?.  56:A187-A187. 2001
  • Clinical carotid endarterectomy decision making: noninvasive vascular imaging versus angiography..  56:1009-1015. 2001
  • Use of specialized coagulation testing in the evaluation of patients with acute ischemic stroke..  56:624-627. 2001
  • Assessment of aspiration risk in stroke patients with quantification of voluntary cough..  56:502-506. 2001
  • Use and cost of hospitalization of patients with AD by stage and living arrangement: CERAD XXI..  56:201-206. 2001
  • Mycophenolate mofetil for myasthenia gravis: an open-label pilot study..  56:97-99. 2001
  • Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases..  56:94-96. 2001
  • Tetrabenazine for Huntington's disease chorea: A single-blind study.  56:A23-A23. 2001
  • Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias..  55:1158-1166. 2000
  • Cortical MRI findings associated with rapid correction of hyponatremia..  55:1048-1051. 2000
  • Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society..  55:468-479. 2000
  • Retrospective analysis of the use of cyclosporine in myasthenia gravis..  55:448-450. 2000
  • Glutamate decarboxylase is not genetically linked to pyridoxine-dependent seizures..  55:309-311. 2000
  • Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial..  55:236-242. 2000
  • Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America..  55:16-23. 2000
  • The incidence of dementia in Canada.  55:66-73. 2000
  • Hippocampal sulcal cavities on MRI: relationship to age and apolipoprotein E genotype..  54:2150-2153. 2000
  • Lambert-Eaton myasthenic syndrome: electrodiagnostic findings and response to treatment..  54:2176-2178. 2000
  • Testing a test: a report card for DWI in acute stroke..  54:1549-1551. 2000
  • Effort and awareness in unilateral spatial neglect.  54:A223-A224. 2000
  • Familial clustering of intracerebral hemorrhage.  54:A262-A263. 2000
  • Variability of the mini-mental state examination in dementia..  54:1538-1539. 2000
  • Dementia diagnoses from clinical and neuropsychological data compared: the Cache County study..  54:1290-1296. 2000
  • Benign prognosis of never-symptomatic carotid occlusion..  54:878-882. 2000
  • A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome..  54:603-607. 2000
  • APOE and AD concordance in twin pairs as predictors of AD in first-degree relatives..  54:593-598. 2000
  • Acute hydrocephalus in nonketotic hyperglycinemia..  54:754-756. 2000
  • Frequency and duration of hospitalization of patients with AD based on Medicare data: CERAD XX..  54:740-743. 2000
  • Seizure outcome after temporal lobectomy for temporal lobe epilepsy: a Kaplan-Meier survival analysis..  54:630-634. 2000
  • Isolated musculocutaneous neuropathy caused by a proximal humeral exostosis..  54:494-496. 2000
  • Intracerebral hemorrhage outcome: apolipoprotein E genotype, hematoma, and edema volumes..  53:2176-2179. 1999
  • Critical decline in fine motor hand movements in human aging..  53:1458-1461. 1999
  • Crossmodal and sensorimotor integration in tactile awareness..  53:1596-1598. 1999
  • A novel antineuronal antibody in a motor neuron syndrome associated with breast cancer..  53:852-855. 1999
  • Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis..  53:699-708. 1999
  • Mortality in elderly Canadians with and without dementia: a 5-year follow-up..  53:521-526. 1999
  • APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study..  53:321-331. 1999
  • Cerebral hemodynamic impairment: methods of measurement and association with stroke risk..  53:251-259. 1999
  • Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX..  52:1839-1844. 1999
  • Angiographically defined primary angiitis of the CNS: Is it really benign? [4] (multiple letters).  52:1302-1303. 1999
  • Neuroendocrine lung tumors and disorders of the neuromuscular junction..  52:1490-1491. 1999
  • Survival and outcome after endotracheal intubation for acute stroke..  52:1374-1381. 1999
  • Angiographically defined primary angiitis of the CNS: is it really benign?.  52:1302. 1999
  • Vitamin E intake: A primary preventive measure in stroke.  52:A146-A146. 1999
  • The effects of mannitol on cerebral edema after large hemispheric cerebral infarct..  52:583-587. 1999
  • Respiratory management in acute CNS catastrophies [4] (multiple letters).  52:217-218. 1999
  • Evaluation of the alpha(2A)-adrenergic receptor gene in a heritable form of temporal lobe epilepsy..  51:1730-1731. 1998
  • Seizure onset from periventricular nodular heterotopias: depth-electrode study..  51:1723-1727. 1998
  • Asymptomatic McArdle's disease associated with hyper-creatine kinase-emia and absence of myophosphorylase..  51:1228-1229. 1998
  • Inaccuracy of the ICD-9-CM in identifying the diagnosis of ischemic cerebrovascular disease.  51. 1998
  • Inaccuracy of the ICD-9-CM in identifying the diagnosis of ischemic cerebrovascular disease.  51. 1998
  • Inaccuracy of the ICD-9-CM in identifying the diagnosis of ischemic cerebrovascular disease..  51:921. 1998
  • Inaccuracy of the ICD-9-CM in identifying the diagnosis of ischemic cerebrovascular disease..  51:921-922. 1998
  • The value of stroke prevention and treatment..  51:S31-S35. 1998
  • Migratory leptomeningeal inflammation with relapsing polychondritis..  51:614-617. 1998
  • Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease..  51:159-162. 1998
  • Comparison of valproate and phenobarbital treatment after status epilepticus in rats..  51:41-48. 1998
  • Longitudinal MRI findings in pyridoxine-dependent seizures..  51:74-78. 1998
  • Progression of Alzheimer's disease in black and white patients: the CERAD experience, part XVI. Consortium to Establish a Registry for Alzheimer's Disease..  51:154-158. 1998
  • A cross sectional study on the health related quality of life and health service utilization for mild, moderate, and severely impaired Alzheimer's disease patients.  50:A303-A303. 1998
  • Induced controlled extended hypothermia improves outcomes in malignant stroke.  50:A412-A413. 1998
  • Magnetic resonance imaging in acute stroke: not ready for prime time..  50:842-843. 1998
  • Pre-attentive processes in vision.  50:A256-A257. 1998
  • Survival, functional outcome, and quality of life following endotracheal intubation for acute stroke.  50:A413-A413. 1998
  • Respiratory management in acute neurologic illness..  50:11-20. 1998
  • Surgical treatment of carpal tunnel syndrome in patients with peripheral neuropathy..  49:1159-1163. 1997
  • Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia..  49:701-707. 1997
  • Clinical and electrographic manifestations of lesional neocortical temporal lobe epilepsy..  49:757-763. 1997
  • Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease..  49:660-664. 1997
  • Neuropsychological assessment of Alzheimer's disease..  49:S11-S13. 1997
  • Overview: clinical sites, case material, and special studies..  49:S2-S6. 1997
  • The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease..  49:70-75. 1997
  • The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials..  48:1511-1517. 1997
  • Object shape processing in the visual system evaluated using functional MRI..  48:1416-1420. 1997
  • Predictors of time to institutionalization of patients with Alzheimer's disease: the CERAD experience, part XVII..  48:1304-1309. 1997
  • Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition..  48:985-989. 1997
  • Seronegative myasthenia gravis.  48. 1997
  • Surgical treatment of carpal tunnel syndrome in patients with peripheral neuropathy.  48:3114-3114. 1997
  • Hypsarrhythmia: frequency of variant patterns and correlation with etiology and outcome..  48:197-203. 1997
  • Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase..  48:55-57. 1997
  • Spinal cord infarction: Reply from the authors.  48:1478. 1997
  • Treatment of acquired myasthenia gravis.  48. 1997
  • Quantitation of epidermal nerves in diabetic neuropathy.  47:1042-1048. 1996
  • Apolipoprotein E and cognitive decline in Alzheimer's disease..  47:317-320. 1996
  • Spinal cord infarction: etiology and outcome..  47:321-330. 1996
  • X-linked malformations of neuronal migration..  47:331-339. 1996
  • Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group..  47:68-76. 1996
  • Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group..  46:1507-1514. 1996
  • NSAIDs and cognition in Alzheimer's disease..  46:1194. 1996
  • Cerebral infarction associated with Kearns-Sayre syndrome-related cardiomyopathy..  46:826-828. 1996
  • Inpatient costs of specific cerebrovascular events at five academic medical centers..  46:854-860. 1996
  • Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old?.  46:641-650. 1996
  • The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease..  46:656-660. 1996
  • Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis, Part XII..  46:136-141. 1996
  • Delayed-onset progressive movement disorders after static brain lesions..  46:68-74. 1996
  • Neuro-Behcet's disease in Japan - Reply.  47:614-615. 1996
  • Plasmapheresis in Rasmussen's encephalitis..  46:242-246. 1996
  • Reply from the Author: Stroke recovery.  46:1187-1188. 1996
  • Reply from the Authors: Delayed-onset dyskinesias.  47:1359. 1996
  • The consortium to establish a registry for Alzheimer's Disease (CERAD). Part XIII. Obtaining autopsy in Alzheimer's disease..  46:142-145. 1996
  • Neuropsychological test performance in African-American and white patients with Alzheimer's disease..  45:2207-2211. 1995
  • Cognitive performance on the Alzheimer's Disease Assessment Scale: effect of education..  45:1980-1984. 1995
  • Comparison and meta-analysis of randomized trials of endarterectomy for symptomatic carotid artery stenosis..  45:1965-1970. 1995
  • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease..  45:1991-1995. 1995
  • Neuro-Behçet's disease: factors hampering proper diagnosis..  45:1754-1757. 1995
  • Intelligence and education as predictors of cognitive state in late life: a 50-year follow-up..  45:1446-1450. 1995
  • Proton magnetic resonance spectroscopic imaging in childhood ataxia with diffuse central nervous system hypomyelination..  45:1526-1532. 1995
  • Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease..  45:1323-1328. 1995
  • Circulating adhesion molecules and inflammatory mediators in demyelination: a review..  45:S22-S32. 1995
  • Common drugs may influence motor recovery after stroke. The Sygen In Acute Stroke Study Investigators..  45:865-871. 1995
  • METAANALYSIS AND COMPARISON OF RANDOMIZED TRIALS OF ENDARTERECTOMY FOR SYMPTOMATIC CAROTID STENOSIS.  45:A375-A375. 1995
  • The syndrome of frontal lobe epilepsy: characteristics and surgical management..  45:780-787. 1995
  • Re: MRI in Guillain-barré syndrome.  45:1024. 1995
  • The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease..  45:178-179. 1995
  • Apolipoprotein E epsilon 4..  44:2420-2421. 1994
  • CERAD part VII: accuracy of reporting dementia on death certificates of patients with Alzheimer's disease..  44:2208-2209. 1994
  • The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada..  44:2073-2080. 1994
  • Treatment of radiation-induced nervous system injury with heparin and warfarin..  44:2020-2027. 1994
  • Flunarizine for treatment of partial seizures: results of a concentration-controlled trial..  44:1830-1836. 1994
  • Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapy..  44:1721-1727. 1994
  • Magnetic resonance imaging of the cauda equina in Guillain-Barré syndrome..  44:1334-1336. 1994
  • Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis..  44:1208-1214. 1994
  • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part VI. Family history assessment: a multicenter study of first-degree relatives of Alzheimer's disease probands and nondemented spouse controls..  44:1253-1259. 1994
  • A follow-up survey of clinical practices for the use of heparin, warfarin, and aspirin..  44:618-621. 1994
  • INTELLIGENCE AND EDUCATION AS PREDICTORS OF COGNITIVE STATE IN LATE-LIFE - A 50-YEAR FOLLOW-UP.  44:A141-A141. 1994
  • Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study..  44:652-656. 1994
  • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery..  44:609-614. 1994
  • Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study..  44:227-232. 1994
  • Apolipoprotein E ε4.  44:2420. 1994
  • The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease..  43:2457-2465. 1993
  • Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group..  43:2284-2291. 1993
  • Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease..  43:1467-1472. 1993
  • Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy..  43:1088-1092. 1993
  • Acetylcholine receptor antibodies in juvenile myasthenia gravis..  43:977-982. 1993
  • Relapse in Guillain-Barré syndrome after treatment with human immune globulin..  43:872-875. 1993
  • ECT-induced status..  43:847-848. 1993
  • Acute hypertension after stroke: the scientific basis for treatment decisions..  43:461-467. 1993
  • Aspiration in bilateral stroke patients: a validation study..  43:430-433. 1993
  • Use of twin cohorts for research in Alzheimer's disease..  43:261-267. 1993
  • In vitro MR microscopy of the hippocampus in Alzheimer's disease..  43:145-152. 1993
  • Quiescent and cycling cell compartments in the senescent and Alzheimer-diseased human brain..  43:87-94. 1993
  • A syndrome of autosomal dominant alternating hemiplegia: clinical presentation mimicking intractable epilepsy; chromosomal studies; and physiologic investigations..  42:2251-2257. 1992
  • Accuracy and interobserver reliability of scalp ictal EEG..  42:2279-2285. 1992
  • The epidemiology of myasthenia gravis in central and western Virginia..  42:1888-1893. 1992
  • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part III. Reliability of a standardized MRI evaluation of Alzheimer's disease..  42:1676-1680. 1992
  • Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease..  42:765-770. 1992
  • Linkage studies in Charcot-Marie-Tooth disease type 2: evidence that CMT types 1 and 2 are distinct genetic entities..  42:597-601. 1992
  • Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging..  42:527-536. 1992
  • Cognitive functioning in cancer patients: effect of previous treatment..  42:434-436. 1992
  • Very-late-onset adrenoleukodystrophy: possible precipitation of demyelination by cerebral contusion..  42:367-370. 1992
  • Truncal asterixis associated with ceftazidime, a third-generation cephalosporin..  41:2008. 1991
  • Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas..  41:1741-1744. 1991
  • Technology assessment revisited: does positron emission tomography have proven clinical efficacy?.  41:1339-1340. 1991
  • Single-fiber EMG demonstrates reinnervation dynamics after nerve injury..  41:1150-1151. 1991
  • Chronic inflammatory demyelinating polyradiculoneuropathy of childhood: treatment with high-dose intravenous immunoglobulin..  41:828-830. 1991
  • MRI quantification..  41:954-955. 1991
  • MRI quantification..  41:954-955. 1991
  • Multiple sclerosis, retroviruses, and PCR. The HTLV-MS Working Group..  41:335-343. 1991
  • Sagittal sinus thrombosis and leptomeningeal medulloblastoma..  41:455-456. 1991
  • A case of myelinoclastic diffuse sclerosis in an adult..  41:316-318. 1991
  • Aspiration in bilateral stroke patients..  40:1686-1688. 1990
  • Borderzone hemodynamics in cerebrovascular disease..  40:1587-1592. 1990
  • Neonatal herpes simplex meningoencephalitis: EEG investigations and clinical correlates..  40:1433-1437. 1990
  • Toluene dementia..  40:1320-1321. 1990
  • Low yield in the diagnostic evaluation of transient ischemic attacks..  40:747-748. 1990
  • Presymptomatic and prenatal diagnosis in myotonic dystrophy by genetic linkage studies..  40:671-676. 1990
  • Anterior temporal lobectomy for complex partial seizures: evaluation, results, and long-term follow-up in 100 cases..  40:413-418. 1990
  • Tight linkage of creatine kinase (CKMM) to myotonic dystrophy on chromosome 19..  40:222-226. 1990
  • Neologistic speech automatisms during complex partial seizures..  40:49-52. 1990
  • Reply: Speech automatisms.  40:1320. 1990
  • Speech automatisms (I: Reply).  40:1320. 1990
  • Familial X-linked myalgia and cramps: a nonprogressive myopathy associated with a deletion in the dystrophin gene..  39:1277-1280. 1989
  • Neurobehavioral changes with caudate lesions..  39:1410-1411. 1989
  • Femoral compression neuropathy from a mechanical pressure clamp..  39:1263. 1989
  • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease..  39:1159-1165. 1989
  • Dimple sign in mail carrier's ulnar neuropathy..  39:1132. 1989
  • Neurogenic claudication with positionally dependent weakness from a thoracic disk herniation..  39:1133-1134. 1989
  • Linkage analysis in familial amyotrophic lateral sclerosis..  39:919-925. 1989
  • Time course of carbamazepine autoinduction. The VA Cooperative Study No.118 Group..  39:592-594. 1989
  • A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke..  39:262-265. 1989
  • Intraoperative brainstem auditory evoked potentials: significant decrease in postoperative morbidity..  39:187-191. 1989
  • Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor..  39:62-66. 1989
  • Physician prescribing patterns following hospital admission for ischemic cerebrovascular disease..  38:1806-1809. 1988
  • Aspiration following stroke: clinical correlates and outcome..  38:1359-1362. 1988
  • The effect of carotid artery disease on the cerebrovascular response to physiologic stimulation..  38:1475-1478. 1988
  • Carbamazepine increases phenytoin serum concentration and reduces phenytoin clearance..  38:1146-1150. 1988
  • Intracranial atherosclerosis following radiotherapy..  38:1158-1160. 1988
  • Asterixis mimicking drop attacks in chronic renal failure..  38:663. 1988
  • Phenobarbital does not alter phenytoin steady-state serum concentration or pharmacokinetics..  38:639-642. 1988
  • Silent aspiration following stroke..  38:317-319. 1988
  • Clinical and genetic investigation in autosomal dominant limb-girdle muscular dystrophy..  38:5-9. 1988
  • Duchenne muscular dystrophy: high frequency of deletions..  38:1-4. 1988
  • Intravenous adenosine selectively increases blood flow to xenotransplanted intracerebral gliomas..  37:1870-1873. 1987
  • Causes of treatment failure with antiepileptic drugs vary over time..  37:1620-1623. 1987
  • Hereditary motor and sensory neuropathy, X-linked: a half century follow-up..  37:1460-1465. 1987
  • Intractable complex partial seizures: the "initial motionless stare" and surgical outcome following temporal lobectomy..  37:1255-1258. 1987
  • Early-onset Alzheimer's disease: clinical predictors of institutionalization and death..  37:980-984. 1987
  • Isolated deficiency of vitamin E with progressive neurologic deterioration..  37:538-540. 1987
  • Prenatal detection of an inherited Duchenne muscular dystrophy deletion allele..  37:355-356. 1987
  • Tight linkage of apolipoprotein C2 to myotonic dystrophy on chromosome 19..  36:1418-1423. 1986
  • A new tightly linked DNA probe for myotonic dystrophy..  36:1146. 1986
  • Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease..  36:1087-1091. 1986
  • Abnormal sensory evoked potentials in amyotrophic lateral sclerosis..  36:796-801. 1986
  • Botulinum toxin for blepharospasm: single-fiber EMG studies..  36:545-547. 1986
  • Hysteroepilepsy in the nineteenth century: Charcot and Gowers..  36:65-67. 1986
  • Neurologic presentation of decompression sickness and air embolism in sport divers..  35:667-671. 1985
  • Myocardial infarction and stroke..  34:1403-1409. 1984
  • Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum..  34:1208-1212. 1984
  • Extracranial-intracranial bypass surgery: hemodynamic and metabolic effects..  34:1168-1174. 1984
  • Risk of ischemic heart disease in patients with TIA..  34:626-630. 1984
  • Treatment of patients with recurrent primary brain tumors with AZQ..  34:615-619. 1984
  • Natural history of cerebral complications of coronary artery bypass graft surgery..  33:1416-1421. 1983
  • Regional blood flow in avian sarcoma virus (ASV)-induced brain tumors..  33:686-696. 1983
  • Regional blood-to-tissue transport in avian sarcoma virus (ASV)-induced brain tumors..  33:702-711. 1983
  • A design for the prospective evaluation of the efficacy and toxicity of antiepileptic drugs in adults..  33:14-25. 1983
  • A method of quantification for the evaluation of antiepileptic drug therapy..  33:26-37. 1983
  • Indium-111 platelet scintigraphy in cerebrovascular disease..  32:938-943. 1982
  • Ocular bobbing in metabolic encephalopathy: clinical, pathologic, and electrophysiologic study..  32:1029-1031. 1982
  • Chronic dopamine agonist treatment in an animal model of tardive dyskinesia: Differential effect on pre- and postsynaptic receptor sensitivity.  32. 1982
  • Evaluation of two new dopamine agonists.  32. 1982
  • TIA, stroke, and the bicuspid aortic valve..  31:1540-1542. 1981
  • Erythromelalgia-like eruption in parkinsonian patients treated with bromocriptine..  31:1368-1370. 1981
  • Mental neuropathy from systemic cancer..  31:1277-1281. 1981
  • Arsenic neuropathy..  31:1057-1058. 1981
  • Sarcoidosis mimicking glioma: case report and review of intracranial sarcoid mass lesions..  31:907-910. 1981
  • Electromyographic evaluation of notalgia paresthetica..  31:642. 1981
  • Scintigraphy with indium-111 platelets in cerebrovascular disease.  31:55. 1981
  • Effects of oral choline on human complex partial seizures..  30:1334-1336. 1980
  • Experimental dystonia induced by quaternary-chlorpromazine..  30:878-881. 1980
  • Passive transfer of human myasthenia gravis to rats: 1. Electrophysiology of the developing neuromuscular block..  30:760-764. 1980
  • Experimental gliomas: an autoradiographic study of the endothelial component..  30:297-301. 1980
  • Evidence for an agonist-independent decline of hippocampal muscarinic receptors in kindling.  30. 1980
  • Repeated seizures induce increased numbers of hippocampal benzodiazepine receptors.  30. 1980
  • Nevus of Ota and intracranial arteriovenous malformation..  29:1625-1627. 1979
  • Unilateral asterixis: motor integrative dysfunction in focal vascular disease..  29:1180-1182. 1979
  • Erythromelalgia-like eruption in parkinsonian patients treated with bromocriptine.  29:571. 1979
  • Handcuff-related cheiralgia paresthetica.  29:909. 1979
  • Notalgia paresthetica.  29:528. 1979
  • Single-fiber electromyography in myasthenia gravis..  29:68-76. 1979
  • Handcuffs and cheiralgia paresthetica..  28:1312-1313. 1978
  • Notalgia paresthetica..  28:1310-1312. 1978
  • Muscarinic cholinergic receptors participate in the kindling model of epilepsy.  28:346. 1978
  • Short-term effects of prednisolone on neuromuscular transmission in experimental autoimmune myasthenia gravis and in normal rats.  28:336. 1978
  • The effect of oral glycerol on intraventricular pressure in man..  27:600-608. 1977
  • The value of carotid endarterectomy in treating transient cerebral ischemia of the posterior circulation..  27:682-684. 1977
  • Rapid changes in brain beta adrenergic receptors.  27:395. 1977
  • Receptor binding studies in kindling.  27:374. 1977
  • Prolonged twilight state and automatisms: a case report..  24:331-339. 1974
  • Administration of 5-hydroxy-L-tryptophan to individuals with Huntington's chorea..  22:1201-1204. 1972
  • An improved method of preparing Schmidt-Ruppin Rous sarcoma virus for brain tumor induction in mammals..  20:413. 1970
  • Effects of low frequency stimulation on the monosynaptic reflex (H reflex) in man..  18:47-51. 1968
  • Antagonistic muscles in the production of clonus in man..  17:779-81, 796. 1967
  • CHEMICAL STIMULATION OF RED NUCLEUS, SUBSTANTIA NIGRA, AND BASIS PEDUNCULI IN ALERT CATS..  15:604-612. 1965
  • Enhancing Pandemic-Sensitive Recruitment Strategies for a Remote, Randomized Placebo-Controlled Trial for Fracture Prevention in Patients with Neurodegenerative Parkinsonisms (P1-1.Virtual) 2022
  • Frequency, Persistence, and Patient-reported Outcomes of Neurological Symptoms in Mild COVID-19: Results from the ALBERTA HOPE COVID-19 Trial 2022
  • International COVID-19D AY, Vaccine Experience and Perceptions Survey In Patients with Myasthenia Gravis: An (P18-2.003) 2022
  • Pathogenic Th17 Cells in Autoimmune Myasthenia Gravis Exhibit a Pro-inflammatory Transcriptomic Signature that Promotes Disease Pathogenesis 2022
  • Analysis of the Duke Myasthenia Gravis (MG) Clinic Registry: Thymectomy 2021
  • Efficacy and Safety Results of the Avalglucosidase alfa Phase 3 COMET Trial in Late-Onset Pompe Disease Patients 2021
  • Extracranial Hemorrhage in the Setting of Gastrointestinal or Genitourinary Cancer is Associated with Increased Risk of Ischemic Stroke in Patients with Atrial Fibrillation 2021
  • Neuro-Jeopardy and Neurophobia: Lessons from a Pilot Intervention 2021
  • Stroke Utilization and Outcomes Under Alternative Payment Models: A Systematic Review 2021
  • Sustained Benefits for 10 kHz Spinal Cord Stimulation Treatment of Painful Diabetic Neuropathy - Six Month Results from a Multicenter Randomized Controlled Trial 2021
  • Vivacity-MG: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis 2021
  • 10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial 2020
  • Analysis of the Duke Myasthenia Gravis (MG) Clinic Registry: Demographic and Clinical Characteristics 2020
  • Carepartner Communication on Parkinson Disease Psychosis 2020
  • Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study 2020
  • Creation of a National Real-World Data Pediatric Migraine Registry: Proof of Principle 2020
  • Determination of sensitivity and specificity of live clustered cell based acethylcholine antibody assay in a well characterized cohort of adult myasthenia gravis patients 2020
  • Effect of Complement Inhibition on Lymphocytes in Treatment Refractory Myasthenia Gravis Patients 2020
  • Home-Based Electrical Impedance Myography in Late-Onset Pompe Disease 2020
  • Investigation of S-Nitrosoglutathione in Stroke: A Systematic Review and Meta-Analysis of Literature in Pre-clinical and Clinical Research 2020
  • NEO1 and NEO-EXT Studies: Long-Term Safety and Exploratory Efficacy of Repeat Avalglucosidase Alfa Dosing for 5.5 Years in Late-Onset Pompe Disease Patients 2020
  • Onasemnogene Abeparvovec-xioi Gene-Replacement Therapy for Spinal Muscular Atrophy Type 1 (SMA1): Phase 3 US Study (STR1VE) Update 2020
  • PROMISE-MG: Comparative Effectiveness Study of MG Treatments-Baseline Data 2020
  • Transcriptomic Analysis of Rapid Glioblastoma Progressors 2020
  • Primary brain tumors admitted to the neurological intensive care unit: a single institution observational study 2019
  • Primary brain tumors admitted to the neurological intensive care unit: a single institution observational study. 2019
  • AVXS-101 Gene-Replacement Therapy (GRT) for Spinal Muscular Atrophy Type 1 (SMA1): Pivotal Phase 3 Study (STR1VE) Update 2019
  • Consensus Guidelines: MRI surveillance of Children with Presymptomatic Adrenoleukodystrophy 2019
  • Healing Headaches: Evidence-Based Care to Accelerate Pain-Free Time for Children with Migraines in the Emergency Department 2019
  • ITI-214, A Novel Phosphodiesterase I Inhibitor for the Treatment of Parkinson's Disease: Results from A Phase I/II Clinical Study 2019
  • Identifying Reliable Measures of Impairment in Focal Hand Dystonia Patients 2019
  • NEO1 and NEO-EXT Studies: Long-Term Safety of Repeat Avalglucosidase Alfa Dosing for 4.5 Years in Patients With Late-Onset Pompe Disease 2019
  • Neurological and neuroscience education: mitigating neurophobia to mentor health care providers 2019
  • Novel Oral Anticoagulants (NOACs) vs. Warfarin in the Treatment of Cerebral venous Sinus Thrombosis (CVST): A retrospective study of functional and radiographic outcomes among patients enrolled in BEAST (Biorepository to Establish the Aetiology of Sinovenous Thrombosis) at UVA 2019
  • Physical Activity and Rates of Cognitive Decline in Early Parkinson Disease 2019
  • Prevalence and Healthcare Resource Utilization of Community-acquired and Nosocomial Bacterial Meningitis Infections in the United States 2019
  • Self-Reported and Objective Monitoring of Physical Activity in Parkinson Disease 2019
  • Similarities and Differences in Intracerebral Hemorrhage Risk Factors by Race/Ethnicity 2019
  • A Life Saving Treatment in an Adolescent Girl Presenting with Headache and Stupor 2019
  • Anti-GAD Antibody Associated Encephalitis: A Child with Epilepsia Partialis Continua and Ataxia 2019
  • Carbon Monoxide exposure, a red herring in a patient with rapidly progressive dementia, later diagnosed with Creutzfeldt-Jakob disease 2019
  • Genetic Testing - Muddying the Water for Diagnosis of Inflammatory Myopathies 2019
  • Progressive multifocal Leukoencephalopathy in an Immunocompetent Patient: A Rare Case with Radiologic-Pathologic Correlation 2019
  • Adult Pilocytic Astrocytoma: Clinical Management and Prognostic Factors 2018
  • Long-term outcomes of adult patients with ependymoma. 2018
  • Checkpoint Inhibitor-Induced Central Nervous System Autoimmunity: A Case Series 2018
  • Clinical Care and Outcomes of Asian-American Acute Ischemic Stroke Patients 2018
  • First-in-human Study of ATB200/AT2221 in Patients with Pompe Disease: Preliminary Results From the ATB200-02 Trial 2018
  • Hypocupremia induced Encephalomyelopathy with CSF Oligoclonal Bands 2018
  • Lambert-Eaton Myasthenia With and Without Cancer: Clinical Characteristics and Long-term Survival 2018
  • Nervus Intermedius Neuralgia Caused By Craniofacial Fibrous Dysplasia In A Pediatric Patient: A Case Report And Literature Review 2018
  • Novel Phenotype of ATP1A3 Mutation Starting in Infancy 2018
  • Racial Variation in Comfort Measures Only Status in Patients with Intracerebral Hemorrhage 2018
  • Tacrolimus Inhibits Th1 and Th17 Responses in MuSK-MG Patients 2018
  • A case of remission from multifocal motor neuropathy following rituximab 2018
  • Cerebellar Ataxia Renal-failure Neuropathy with Encephalopathy (mt-CARNE): A New Mitochondrial Syndrome Identified by Sequencing Frozen Nerve and Kidney Tissue DNA 2018
  • Clinical Vignette: Limbic Encephalitis Presenting as Bilateral Epilepsia Partialis Continua 2018
  • Lymphomatoid Papulosis in a 37-year-old Woman with Relapsing Multiple Sclerosis Treated with Dimethyl Fumarate 2018
  • Phenotypic and muscle biopsy features of patients with FKRP c.1387A > G founder mutation 2018
  • Pulmonary-Sparing Anti-MDA5-Positive Dermatomyositis with Scleroderma Overlap, Glomerulonephritis and Cardiomyopathy 2018
  • Tumor stem cell RNA-leaded dedritic cell vaccine for recurrent glioblastoma: a phase 1 trail. 2017
  • A Case of GLUT1 Deficiency Associated Episodic Ataxia Without Epilepsy 2017
  • Feasibility of Google Glass for Remote Resident Supervision and Evaluation 2017
  • Impact of Review Sessions on NBME Subject Examination Performance 2017
  • Interplay Between LRRK2 Action in Neurons and Macrophages in Mediating alpha-Synuclein linked Neurodegeneration 2017
  • Managing Myasthenia Gravis with Immunosuppressive Drugs: Lessons from the Patient Perspective 2017
  • Novel Clinical Presentations and Characteristics in Patients with KCNA2 Mutations 2017
  • Quality Improvement for the Management of Pediatric Patients with Status Epilepticus 2017
  • Racial differences in the diagnosis of atypical parkinsonism 2017
  • Utility of Physical Disability Outcome Measures in Pediatric-Onset Multiple Sclerosis 2017
  • A Simple Bedside Grading Scale Can Effectively Predict Severe Post-Stroke Upper-Extremity Spasticity 2016
  • Difficult Conversations in Neurology: Defining Medical Student Exposure and Educational Opportunities 2016
  • Effects of Therapeutic Plasma Exchange on Myasthenic Outcome Measures 2016
  • Effects of Therapeutic Plasma Exchange on Myasthenic Outcome Measures 2016
  • Factors Considered by Physicians Versus Nurses When Prognosticating Acute Intracerebral Hemorrhage Outcomes 2016
  • Functional and I aging Studies of the Selective Inhibitor of Nuclear Export (SINE) Compound KPT-350 in a Clinically Relevant Murine Model of Closed Head Injury (CHI) 2016
  • Functional and Imaging Studies of the Selective Inhibitor of Nuclear Export (SINE) Compound KPT-350 in a Clinically Relevant Murine Model of Closed Head Injury (CHI) 2016
  • Functional and Imaging Studies of the Selective Inhibitor of Nuclear Export (SINE) Compound KPT-350 in a Clinically Relevant Murine Model of Closed Head Injury (CHI) 2016
  • Functional and Imaging Studies of the Selective Inhibitor of Nuclear Export (SINE) Compound KPT-350 in a Clinically Relevant Murine Model of Closed Head Injury (CHI) 2016
  • Functional and Imaging Studies of the Selective Inhibitor of Nuclear Export (SINE) Compound KPT-350 in a Clinically Relevant Murine Model of Closed Head Injury (CHI) 2016
  • Narrow Therapeutic Index Classification of Antiepileptic Drugs Using a Comprehensive Literature Search 2016
  • Narrow Therapeutic Index Classification of Antiepileptic Drugs Using a Comprehensive Literature Search 2016
  • PIK3CA Mutation in a Mixed Rosette Forming Glioneuronal Tumor and Dysembryoplastic Neuroepithelial Tumor 2016
  • The effect of 24 hour post-intravenous alteplase CT head on management decisions: a single center experience 2016
  • The effect of 24 hour post-intravenous alteplase CT head on management decisions: a single center experience 2016
  • Validation of the Sporadic Inclusion Body Myositis Physical Functioning Assessment 2016
  • Difficult Conversations in Neurology: Defining Medical Student Exposure and Educational Opportunities 2016
  • Factors Considered by Physicians Versus Nurses When Prognosticating Acute Intracerebral Hemorrhage Outcomes 2016
  • Functional and Imaging Studies of the Selective Inhibitor of Nuclear Export (SINE) Compound KPT-350 in a Clinically Relevant Murine Model of Closed Head Injury (CHI) 2016
  • A Multicenter Phase II Open-Label Trial of L-Carnitine and Valproic Acid in Infants with Spinal Muscular Atrophy Type I 2013
  • Characterization of Radiation Necrosis in Long-Term Survivors (LTS) of Primary Glioblastoma 2013
  • Does Change in Acetylcholine Receptor Antibody (AChR-Ab) Level Predict or Correlate with Clinical Change in Myasthenia Gravis (MG)? 2013
  • SNP rs10940495 in the Gp-130 Locus Is Associated with Functional Outcome Following Spontaneous Intracerebral Hemorrhage 2013
  • International Comparison of Resource Use Trajectories after Stroke 2013
  • Muscle Ultrasonography Changes over One Year in Duchenne and Becker Muscular Dystrophy 2013
  • Upper Extremity Peripheral Nerve Ultrasound Shows Proximal to Distal Tapering of Nerves in Demyelinating Charcot-Marie-Tooth Disease but Not in Acquired Inflammatory Demyelinating Neuropathies 2013
  • Can Mycophenolate Mofetil Be Successfully Tapered in Myasthenia Gravis? 2012
  • Do Clinical Characteristics Predict Response to Mycophenolate Mofetil in Myasthenia Gravis? 2012
  • Improved Clinical Outcomes in Medicare Beneficiaries with Acute Ischemic Stroke during Initial Implementation of the Get with the Guidelines-Stroke Program 2003-2008 2012
  • Improved Clinical Outcomes in Medicare Beneficiaries with Acute Ischemic Stroke during Initial Implementation of the Get with the Guidelines-Stroke Program 2003-2008 2012
  • Evaluation of Long-Term Treatment with Lacosamide for Partial-Onset Seizures: A Pooled Analysis of Open-Label Extension Trials 2012
  • Complex Information Processing Abnormalities in Relapsing-Remitting Multiple Sclerosis 2011
  • Correlation of Carpal Tunnel Severity to Ultrasonographic Median Nerve Cross Sectional Area 2011
  • Prognostic Value of Clinical Response to Acetylcholinesterase Inhibitors in Myasthenia Gravis with Anti-MuSK Antibodies 2011
  • Timing of Hospital Arrival among GWTG Stroke Participants 2003-2009: Trends, Variations, and Implications 2011
  • Ultrasound and Electrodiagnostic Findings in Acute Inflammatory Demyelinating Polyradiculoneuropathy with Facial Neuropathy 2011
  • Long-Term Efficacy of Lacosamide as Adjunctive Therapy in Patients with Uncontrolled POS: Results from a Phase III Open-Label Extension Trial 2011
  • Long-Term Safety of Lacosamide as Adjunctive Therapy in Patients with Uncontrolled Partial-Onset Seizures: Results from a Phase III Open-Label Extension Trial 2011
  • Analysis of Cardiac Involvement in Children and Adults with Pompe Disease from the Pompe Registry 2010
  • Are Periventricular Lesions Specific for Multiple Sclerosis? 2010
  • Fatal Muscular Dystrophy, Congenital Myasthenic Syndrome (CMS), and Epidermolysis Bullosa Simplex (EBS) Due to Plectin Deficiency 2010
  • Higher Cognitively Functioning Relapsing-Remitting Multiple Sclerosis Patients Have a More Specific Pattern of Impairment on Neuropsychological Testing 2010
  • In Cognitively Healthy and Mildly Impaired Individuals Florbetapir F 18 PET Measures of Amyloid Deposition Correlate with the Degree of Functional Impairment Assessed Six Months Later 2010
  • Retrospective Review of Symptomatic Intracranial Hemorrhage (ICH) in Cancer Patients Treated with Bevacizumab; the Memorial Sloan-Kettering (MSK) Experience 2010
  • Transient Expression of a Therapeutic Dystrophin Transgene in Duchenne Muscular Dystrophy Revealed by T Cell Mediated Immunity 2010
  • Association of the H63D Polymorphism in HFE with ALS in a Population of US Veterans 2009
  • Erythropoietin and Neuroprotection in Ischemic Strokes: A Retrospective Review of Chronic Kidney Failure Patients 2009
  • Variable Heritability of Truncating CLCN1 Mutations in Myotonia Congenita 2009
  • Changes in hippocampal connexin 30, 36, and 43 expression after acute hypoxia in the developing brain 2008
  • Impairment in social and physical domains but not in emotional or school performance domains of quality of life in mentally retarded children in Lebanon 2008
  • Scrutinizing enrollment in ALS clinical trials: Room for improvement? 2008
  • The survival of US military veterans with ALS 2008
  • Alemtuzumab (CAMPATH 1-H) therapy in sporadic inclusion body myositis (sIBM): A treatment trial in patients with established natural history data 2007
  • MuSK antibody positive myasthenia gravis: Response to treatment in 31 patients 2007
  • Is self-reported stroke history reliable in elderly with cognitive impairment? A community-based study 2006
  • Lack of ceramide increase in hypoxia-induced apoptosis in the developing brain of neonatal rats 2006
  • Marked improvements in seizure control and general wellbeing but not in psychosocial or behavioral function after successful epilepsy surgery in children 2006
  • Normalization of quality of life (QOL) three years after temporal lobectomy: A controlled study 2006
  • Risk factors for developing subclinical hypothyroidism during valproic acid therapy 2006
  • Seizure type, sex, and age are predictors of positive response to intravenous gamma globulin (IVIG) in intractable epilepsy 2006
  • The effect of stereotaxic C2-ceramide injection on the inositol triphosphate levels in the hippocampus of adult rats 2006
  • Identification of metabolic and protein biomarkers for amyotrophic lateral sclerosis 2006
  • Correlation between Transcranial Doppler Sonography and CT angiography in detecting vasospasm in aneurysmal subarachnoid hemorrhage 2005
  • Effects of vitamin D therapy on bone density in ambulatory patients on chronic antiepileptic drug therapy: Two randomized trials in children and adults 2005
  • Efficacy of eszopiclone in the treatment of sleep maintenance insomnia 2005
  • Endovascular cerebral aneurysm coil embolization using polymer coated (Matrix (TM)) detachable coils: Preliminary single center experience of 181 aneurysms 2005
  • Incidence of vasospasm in aneurysmal subarachnoid hemorrhage; Surgical clipping versus endovascular coiling 2005
  • Memantine and individual activities of daily living in moderate to severe Alzheimer's disease 2005
  • Predicting optimal stimulation parameters for DBS of the thalamus in essential tremor 2005
  • Randomized, double-blind, placebo-controlled crossover study of donepezil in Down syndrome 2005
  • The eyes have it: Distinct patterns of eye movement abnormalities in FTD relative to AD 2005
  • Twelve months of nightly eszopiclone treatment in patients with chronic insomnia: Assessment of long-term efficacy and safety 2005
  • Cost-effectiveness of antiplatelet agents in secondary stroke prevention: The limits of certainty 2004
  • Acute management of migraine - Highlights of the US Headache Consortium 2003
  • Relationships between Resident Inservice Training Examination and neurology board examination performance 2002
  • Prognostic utility of periodic lateralized epileptiform discharge reactivity 2002
  • Medical student performance of neurologic versus non-neurologic physical examinations on standardized patient examinations 2001
  • Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group. 2000
  • Cortical manifestations of the osmotic myelinolysis syndrome identified by MRI 1999
  • Heroin inhalation and leukoencephalopathy: A case series from California 1999
  • Medical student performance on a simulated neurologic patient evaluation before neurology clerkship 1999
  • Parkinson's disease: Clinical features in sibships 1999
  • Rate and duration of hospitalization and main discharge diagnoses of patients with Alzheimer's disease: Analysis of HCFA records of CERAD subjects 1999
  • Computerized algorithm for stroke subgroup classification using the TOAST criteria 1999
  • Lateralized seizure termination patterns during recordings with depth electrodes: Outcome following temporal lobectomy 1999
  • Prevalence and three-year incidence of dementia in older black and white community residents 1998
  • Comparison of predicted versus measured CPAP in patients with OSAS 1998
  • Is major stroke worse than death?: Results from a survey of preferences among persons at increased risk for stroke 1998
  • Asymptomatic patient with myophosphorylase deficiency, high CK, and the L396P mutation 1997
  • Correlation of acetylcholine receptor antibody binding, modulating and blocking activity with jitter measurements in myasthenia gravis 1997
  • Do acetylcholine receptor antibody binding, modulating and blocking activity measurements correlate with disease severity in myasthenia gravis? 1997
  • Physician-reported stroke prevention practices: Readiness to change 1997
  • Predictive value of ApoE genotyping in a consecutive series of autopsied sporadic probable Alzheimer disease patients 1996
  • Etiology of status epilepticus in institutionalized developmentally disabled clients 1996
  • Clinical features suggestive of nonconvulsive status epilepticus 1996
  • US national survey of physician practices for stroke prevention: Medical therapy in patients with carotid artery stenosis 1996
  • DELAYED-ONSET PROGRESSIVE MOVEMENT-DISORDERS AFTER STATIC BRAIN-LESIONS 1995
  • NATURE OF APHEMIA - LESSONS FROM THE HISTORY OF APHASIOLOGY 1995
  • THE STROKE PREVENTION PATIENT OUTCOMES RESEARCH TEAM - GOALS AND METHODS 1993
  • Post-irradiation neuromyotonia affecting trigeminal nerve distribution: an unusual presentation. 1992
  • DEVELOPMENT OF INFANTILE SPASMS IN SURVIVORS OF NEAR-DROWNING OCCURRING AFTER THE 1ST YEAR OF LIFE 1986
  • NEUROPEPTIDES AND THEIR RECEPTORS IN HUMAN SPINAL-CORD AND DORSAL-ROOT GANGLION NEURONS 1986
  • CHRONIC DOPAMINE AGONIST TREATMENT IN AN ANIMAL-MODEL OF TARDIVE-DYSKINESIA - DIFFERENTIAL EFFECT ON PRE-SYNAPTIC AND POSTSYNAPTIC RECEPTOR SENSITIVITY 1982
  • EVALUATION OF 2 NEW DOPAMINE AGONISTS 1982
  • RAPID CHANGES IN PAROTID ALPHA-ADRENERGIC RECEPTORS 1977
  • Complementary and alternative medicine in the primary brain tumor population and its association with health reported Quality of Life.